Myriad Genetics (MYGN) estimates cut at Morgan Stanley through 2011. Company is seeing higher operating expenses. Equal-weight rating.
O'Reilly Automotive (ORLY) estimates raised at FBR. ORLY estimates were increased through 2010. Underperform rating. Och-Ziff (OZM) estimates, target raised at Goldman. OZM estimates were boosted through 2011. Company is seeing higher asset flows and lower costs. Buy rating and new $15 price target. Royal Caribbean (RCL) estimates raised at UBS. RCL estimates were increased through 2010. Company raised its yield guidance. Neutral rating and $24 price target. Royal Caribbean (RCL) target higher, estimates changed at Barclays. RCL price target raised to $18 from $15. 2009 EPS cut to $0.69 from $0.75, 2010 increased by a quarter to $1.50. Maintain Equal Weight rating. Rowan (RDC) estimates, target increased at Goldman. Shares of RDC now seen reaching $29. Estimates also raised, to reflect better drilling performance and a lower tax rate. Neutral rating. Polo Ralph Lauren (RL) numbers raised at Goldman. RL estimates were increased through 2011. Company guided higher and further sales upside is possible. Buy rating and new $92 price target. Teva Pharma (TEVA) estimates raised at UBS. TEVA estimates increased through 2010. Company continues to execute through a difficult economic environment. Buy rating and $60 price target. Viacom (VIAB) estimates, target boosted at Goldman. VIA.B estimates were raised through 2011. Company is seeing higher Media Networks margins. Buy rating and new $35 price target. Vulcan Materials (VMC) estimates cut at UBS. VMC estimates were lowered through 2010. Stimulus is not hitting the numbers as quickly as expected, and wet weather hurt the company last quarter. Neutral rating and $57 price target. U.S. Steel (X) estimates raised at Morgan Stanley. X estimates were increased through 2010. Steel prices should find support. Equal-weight rating and $53 price target.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |
Connect with TheStreet